Subarachnoid Hemorrhage Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study protocol for ACTIVE study: safety and feasibility evaluation of external ventricular drainage with ACTIVE fluid exchange in intraventricular hemorrhage —a phase 2, multi-center, randomized controlled trial
DiscussionWith no standardized treatment for IVH and a poor prognosis, new treatments are needed. IVH patients often need CSF drainage to treat hydrocephalus and to decrease ICP. Standard treatment with passive external ventricular drainage is related to an increased risk of infections which is found in up to 22% of treated cases. The passive VC is known to have a risk of occlusion and is seen in 19 –47% of the cases.We hypothesize that the use of active fluid change using the IRRAflow system will be safe and feasible and will reduce the occlusion and infection rates in patients with IVH.Trial registrationClicalTrials.go...
Source: Trials - December 29, 2022 Category: Research Source Type: clinical trials

Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage
Condition: Sub-arachnoid Haemorrhage Interventions: Drug: Levosimendan; Other: Placebo Sponsors: Assistance Publique - Hôpitaux de Paris; Orion Corporation, Orion Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2022 Category: Research Source Type: clinical trials